Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Schwabe

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
Gastroenterology|July 22, 2014
Cell death and cell death responses in liver disease: mechanisms and clinical relevanceTom Luedde, Neil Kaplowitz, Robert F Schwabe
Journal of Molecular Medicine (Berlin, Germany)|December 18, 2008
Toll-like receptors, wound healing, and carcinogenesisJohannes Kluwe, Ali Mencin, Robert F Schwabe
Gastroenterology|February 12, 2020
Mechanisms of Fibrosis Development in Nonalcoholic SteatohepatitisRobert F Schwabe, Ira Tabas, Utpal B Pajvani
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 28, 2003
Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migrationRobert F Schwabe, Ramon Bataller, David A Brenner
Seminars in Liver Disease|May 15, 2015
Origin and function of myofibroblasts in the liverRebecca G Wells, Robert F Schwabe, Robert Schwabe
Autophagy|June 30, 2015
Comment on: HMGB1-dependent and -independent autophagyPeter Huebener, Geum Youn Gwak, Robert F Schwabe
Annual Review of Pathology|December 14, 2016
The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver CancerSilvia Affo, Le-Xing Yu, Robert F Schwabe
The Lancet. Gastroenterology & Hepatology|June 29, 2023
Fibroblasts in liver cancer: functions and therapeutic translationSilvia Affo, Aveline Filliol, Gregory J Gores, et al.
Nature Reviews. Gastroenterology & Hepatology|October 14, 2020
Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosisChangyu Zhu, Ira Tabas, Robert F Schwabe, et al.
JHEP Reports : Innovation in Hepatology|July 21, 2025
Antifibrotic therapies for metabolic dysfunction-associated steatotic liver diseaseRobert F Schwabe, Frank Tacke, Atsushi Sugimoto, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
Gastroenterology|July 22, 2014
Cell death and cell death responses in liver disease: mechanisms and clinical relevanceTom Luedde, Neil Kaplowitz, Robert F Schwabe
Journal of Molecular Medicine (Berlin, Germany)|December 18, 2008
Toll-like receptors, wound healing, and carcinogenesisJohannes Kluwe, Ali Mencin, Robert F Schwabe
Gastroenterology|February 12, 2020
Mechanisms of Fibrosis Development in Nonalcoholic SteatohepatitisRobert F Schwabe, Ira Tabas, Utpal B Pajvani
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 28, 2003
Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migrationRobert F Schwabe, Ramon Bataller, David A Brenner
Seminars in Liver Disease|May 15, 2015
Origin and function of myofibroblasts in the liverRebecca G Wells, Robert F Schwabe, Robert Schwabe
Autophagy|June 30, 2015
Comment on: HMGB1-dependent and -independent autophagyPeter Huebener, Geum Youn Gwak, Robert F Schwabe
Annual Review of Pathology|December 14, 2016
The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver CancerSilvia Affo, Le-Xing Yu, Robert F Schwabe
The Lancet. Gastroenterology & Hepatology|June 29, 2023
Fibroblasts in liver cancer: functions and therapeutic translationSilvia Affo, Aveline Filliol, Gregory J Gores, et al.
Nature Reviews. Gastroenterology & Hepatology|October 14, 2020
Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosisChangyu Zhu, Ira Tabas, Robert F Schwabe, et al.
JHEP Reports : Innovation in Hepatology|July 21, 2025
Antifibrotic therapies for metabolic dysfunction-associated steatotic liver diseaseRobert F Schwabe, Frank Tacke, Atsushi Sugimoto, et al.
Pageof 14